在NF2中Merlin蛋白與Hippo信號通路的相互作用
發(fā)布時間:2018-10-29 20:47
【摘要】:正多發(fā)性神經(jīng)纖維瘤病(neurofibromatosis,NF),根據(jù)其臨床及遺傳學(xué)特征分為1型和2型。1930年,Gardner和Frazier證實神經(jīng)纖維瘤、蛐(neurofibromatosis type 2,NF2)為常染色體顯性遺傳性疾病,臨床上通常把NF2分為Wishart型和Gardner型2個亞型。近年來,隨著分子生物學(xué)和細(xì)胞生物學(xué)技術(shù)的廣泛應(yīng)用,已證實位于第22號染色體長臂上的NF2腫瘤抑制
[Abstract]:Multiple neurofibromatosis (neurofibromatosis,NF) is classified into type 1 and type 2 according to its clinical and genetic characteristics. In 1930, Gardner and Frazier confirmed that neurofibromatosis type 鈪,
本文編號:2298780
[Abstract]:Multiple neurofibromatosis (neurofibromatosis,NF) is classified into type 1 and type 2 according to its clinical and genetic characteristics. In 1930, Gardner and Frazier confirmed that neurofibromatosis type 鈪,
本文編號:2298780
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2298780.html
最近更新
教材專著